Treatment therapy dose/schedule
| . | Full-intensity therapy dose/schedule . | Reduced-intensity therapy dose/schedule . |
|---|---|---|
| COP | Cyclophosphamide 300 mg/m2 day 1 | Same |
| Vincristine 1.0 mg/m2 day 1 | ||
| Prednisone 60 mg/m2 (divided doses) days 1-7 | ||
| IT MTX 8-15 mg/m2 day 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 1,3,5 | ||
| IT cytarabine 15-30 mg/m2 days 1,3,5 | ||
| COPADM 1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
| Cyclophosphamide 250 mg/m2 every 12 h days 2-4 | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 days 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
| IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
| COPADM 2 | Vincristine 2.0 mg/m2 d 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) d 1-5 then reduce over 3 d to 0 | ||
| HDMTX 8000 mg/m2 d 1 in 4-h infusion + rescue | ||
| Cyclophosphamide 500 mg/m2 every 12 h d 2-4 | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 days 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
| IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
| CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
| CNS− | HD Ara-C 3000 mg/m2 days 2-5 | |
| Etoposide 200 mg/m2 days 2-5 | ||
| CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
| CNS+ | HD Ara-C 3000 mg/m2 days 2-5 | |
| Etoposide 200 mg/m2 days 2-5 | ||
| IT MTX and hydrocortisone 8-15 mg/m2 day 1 | ||
| HDMTX 8000 mg/m2 day 18* | ||
| IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19* | ||
| Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
| CNS− | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
| Etoposide 100 mg/m2 days 2-5 | ||
| Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
| CNS+ | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
| Etoposide 100 mg/m2 days 2-5 | ||
| HDMTX 8000 mg/m2 day 18† in 4-h infusion + rescue | ||
| IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19† | ||
| M1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| Cyclophosphamide 500 mg/m2 every 12 h days 2,3 | ||
| HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 day 2 | ||
| IT hydrocortisone 8-15 mg/m2 day 2 | ||
| IT cytarabine 15-30 mg/m2 day 2 | ||
| M2 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
| Etoposide 150 mg/m2 days 1-3 | ||
| M3 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Deleted |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| Cyclophosphamide mg/m2 days 1-2 | ||
| Doxorubicin 60 mg/m2 day 1 | ||
| M4 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
| Etoposide 150 mg/m2 days 1-3 |
| . | Full-intensity therapy dose/schedule . | Reduced-intensity therapy dose/schedule . |
|---|---|---|
| COP | Cyclophosphamide 300 mg/m2 day 1 | Same |
| Vincristine 1.0 mg/m2 day 1 | ||
| Prednisone 60 mg/m2 (divided doses) days 1-7 | ||
| IT MTX 8-15 mg/m2 day 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 1,3,5 | ||
| IT cytarabine 15-30 mg/m2 days 1,3,5 | ||
| COPADM 1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
| Cyclophosphamide 250 mg/m2 every 12 h days 2-4 | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 days 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
| IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
| COPADM 2 | Vincristine 2.0 mg/m2 d 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) d 1-5 then reduce over 3 d to 0 | ||
| HDMTX 8000 mg/m2 d 1 in 4-h infusion + rescue | ||
| Cyclophosphamide 500 mg/m2 every 12 h d 2-4 | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 days 1,3,5 | ||
| IT hydrocortisone 8-15 mg/m2 days 2,4,6 | ||
| IT cytarabine 15-30 mg/m2 days 2,4,6 | ||
| CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
| CNS− | HD Ara-C 3000 mg/m2 days 2-5 | |
| Etoposide 200 mg/m2 days 2-5 | ||
| CYVE 1 and 2 | Cytarabine 50 mg/m2 IV days 1-5 | Deleted |
| CNS+ | HD Ara-C 3000 mg/m2 days 2-5 | |
| Etoposide 200 mg/m2 days 2-5 | ||
| IT MTX and hydrocortisone 8-15 mg/m2 day 1 | ||
| HDMTX 8000 mg/m2 day 18* | ||
| IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19* | ||
| Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
| CNS− | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
| Etoposide 100 mg/m2 days 2-5 | ||
| Mini CYVE 1 and 2 | Not applicable | Cytarabine 50 mg/m2 IV days 1-5 |
| CNS+ | Mini HD Ara-C 2000 mg/m2 days 2-5 | |
| Etoposide 100 mg/m2 days 2-5 | ||
| HDMTX 8000 mg/m2 day 18† in 4-h infusion + rescue | ||
| IT MTX, hydrocortisone, Ara-C (dose same as COPADM 1) day 19† | ||
| M1 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Same |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| Cyclophosphamide 500 mg/m2 every 12 h days 2,3 | ||
| HDMTX 8000 mg/m2 day 1 in 4-h infusion + rescue | ||
| Doxorubicin 60 mg/m2 day 2 | ||
| IT MTX 8-15 mg/m2 day 2 | ||
| IT hydrocortisone 8-15 mg/m2 day 2 | ||
| IT cytarabine 15-30 mg/m2 day 2 | ||
| M2 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
| Etoposide 150 mg/m2 days 1-3 | ||
| M3 | Vincristine 2.0 mg/m2 day 1 (maximum: 2.0 mg) | Deleted |
| Prednisone 60 mg/m2 (divided doses) days 1-5 then reduce over 3 d to 0 | ||
| Cyclophosphamide mg/m2 days 1-2 | ||
| Doxorubicin 60 mg/m2 day 1 | ||
| M4 | Cytarabine 50 mg/m2 sq every 12 h days 1-5 | Deleted |
| Etoposide 150 mg/m2 days 1-3 |